Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus

Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus

Introduction: The objective of this study was to understand the potential use of single agents and drug combinations in multiple myeloma (MM) across treatment lines in the years 2021 and 2023. Methods: The method used was Delphi Panel Method survey, administered to European Myeloma Network (EMN) I...

Full description

Bibliographic Details
Main Authors: Mario Boccadoro, Patrizia Berto, Sara Bringhen, Elena Zamagni, Patrizia Tosi, Nicola Cascavilla, Nicola Giuliani, Donato Mannina, Renato Zambello, Francesca Patriarca, Vittorio Montefusco, Mariella Grasso, Francesco Di Raimondo, Massimo Offidani, Maria Teresa Petrucci, Pellegrino Musto
Format: Article
Language:English
Published: AboutScience Srl 2021-07-01
Series:Global & Regional Health Technology Assessment
Subjects:
Delphi Panel
European Myeloma Network
Monoclonal antibodies
Multiple myeloma
Online Access:https://journals.aboutscience.eu/index.php/grhta/article/view/2245

Internet

https://journals.aboutscience.eu/index.php/grhta/article/view/2245

Similar Items